Stock report · Delisted · Nasdaq
Titan Pharmaceuticals Inc (TTNP)
4.61USD Delisted Final close · Oct 1, 2025
TTNP no longer trades. Titan Pharmaceuticals was delisted from the Nasdaq in October 2025.
All prices on this page are historical. The last trade was on October 1, 2025, at $4.61.
TTNP stock price history
Final trading statistics
- Final close
- $4.61
- Final trading day
- Oct 1, 2025
- Market cap at delisting
- $6.13M
- Shares outstanding
- 1.33M
- Final 52-week range
- $3.03 – $5.76
- Avg. volume (final 3 mo.)
- 101,619
- All-time high
- $1000000.00 · Sep 2000
- All-time low
- $3.15 · Jan 2025
- Return since IPO
- -100.0%
- Beta
- 1.38
- Book value / share
- $2.10
- Price / book
- 2.20
About Titan Pharmaceuticals Inc
Titan Pharmaceuticals, Inc. had once developed therapies for chronic diseases but later had no significant operations. Founded in 1991 and based in New York, New York, it was acquired by KE Sdn Bhd in a reverse merger as of October 1, 2025. Its stock was delisted from the Nasdaq in October 2025, with a final trade on October 1, 2025 at $4.61.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New York, NY
- Employees
- —
- IPO date
- January 18, 1996
- Delisted
- October 1, 2025
- SEC CIK
- 910267
Titan Pharmaceuticals financials before the delisting
The last 5 fiscal years Titan Pharmaceuticals reported as a public company, fiscal year ending December.
TTNP revenue and net income
TTNP earnings per share
TTNP annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$4.7M | −$5.23 |
| FY2023 | $1.0K | −$5.6M | −$2.76 |
| FY2022 | $60.0K | −$10.2M | −$5.74 |
| FY2021 | $1.53M | −$8.1M | −$0.90 |
| FY2020 | $4.84M | −$20.7M | −$5.96 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Titan Pharmaceuticals stock FAQ
What happened to Titan Pharmaceuticals stock?
Titan Pharmaceuticals was delisted from the Nasdaq in October 2025. The final close was $4.61 on October 1, 2025.
Can I still buy TTNP stock?
No. TTNP is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on October 1, 2025.
What was the last price of TTNP?
TTNP last closed at $4.61 on October 1, 2025, which valued the company at about $6.13M.
How did Titan Pharmaceuticals do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Titan Pharmaceuticals reported revenue of $0.00 and net income of −$4.7M.
When did Titan Pharmaceuticals go public?
Titan Pharmaceuticals shares started trading on January 18, 1996.
TTNP no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.